Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma
Authors:
- Ketty PerisKPKetty Peris
- Tamara MicantonioTMTamara Micantonio
- Maria Concetta FargnoliMFMaria Concetta Fargnoli
- Gian Piero LozziGLGian Piero Lozzi
- Sergio ChimentiSCSergio Chimenti
- 1 August 2006
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 55 (2) , 324-327
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Dosing With 5% Imiquimod Cream 3 Times per Week for the Treatment of Actinic KeratosisArchives of Dermatology, 2005
- Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studiesJournal of the American Academy of Dermatology, 2004
- Role of Imiquimod in Skin Cancer TreatmentAmerican Journal of Clinical Dermatology, 2004
- Treatment of Bowen's disease of the penis with imiquimod 5% creamClinical and Experimental Dermatology, 2003
- Treatment of Bowen's disease using a cycle regimen of imiquimod 5% creamClinical and Experimental Dermatology, 2003
- Treatment of large facial Bowen's disease: case reportClinical and Experimental Dermatology, 2003
- Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometryBritish Journal of Dermatology, 2002
- Treatment of Bowen's disease of the penis with imiquimodJournal of the American Academy of Dermatology, 2002
- Topical imiquimod 5% cream in the treatment of Bowen's disease of the penisJournal of the American Academy of Dermatology, 2002
- Imiquimod 5% cream in the treatment of Bowen's diseaseJournal of the American Academy of Dermatology, 2001